Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for
numerous cancers, including hepatocellular carcinoma (HCC), the third leading cause of …

Obesity is the primary risk factor for the pathogenesis of non-alcoholic fatty liver disease
(NAFLD), the worldwide prevalence of which continues to increase dramatically. The liver …

Fatty liver disease is a multifactorial world-wide health problem resulting from a complex
interplay between liver, adipose tissue and intestine and initiated by alcohol abuse …

We performed a panoramic analysis on both human nonalcoholic steatohepatitis (NASH)
microarray data and microarray/RNA‐seq data from various mouse models of nonalcoholic …

Background Hyperlipidemia and its complications are among the most harmful of diseases
with a worldwide impact, which creates an urgent imperative to find safe and effective drugs …

Nonalcoholic steatohepatitis may develop into hepatic cirrhosis. The therapeutic drugs for
NASH are absent. Baicalin (BC) has hepatoprotective effect, while whether BC could …

Abstract Alisol B 23-acetate (AB23A) is a natural triterpenoid isolated from the traditional
Chinese medicine rhizoma alismatis, which exhibits a number of pharmacological activities …

Despite the recent substantial progress in the treatment of hepatocellular carcinoma (HCC)
from viral etiology, non-alcoholic steatohepatitis (NASH) is on a trajectory to become the …

Non-alcoholic steatohepatitis (NASH) is a syndrome with simultaneous severe hepatic
steatosis, lobular inflammation and pericelluar fibrosis. The purpose of the present study is …